Fludeoxyglucose F-18 300 mCi/mL

Fludeoxyglucose F-18 300 mCi/mL is an intravenous injection used for diagnostic imaging. This radiopharmaceutical aids in visualizing metabolic activity, commonly employed in positron emission tomography (PET) scans.

Fludeoxyglucose F-18 is primarily used in PET scans to detect areas of high metabolic activity within the body. This can help in evaluating conditions such as cancer, heart disease, and brain disorders. The injection is designed to highlight regions where glucose metabolism is elevated, aiding in diagnostic assessments.

Fludeoxyglucose F-18 works by accumulating in tissues with high glucose metabolism, which can be detected through PET imaging. This process helps healthcare professionals identify areas of concern that may require further investigation.

Handling Fludeoxyglucose F-18 requires adherence to safety protocols due to its radioactive nature. It should be administered by trained professionals in a controlled environment. Proper disposal of any unused product is essential to minimize radiation exposure.

Fludeoxyglucose F-18 may interact with other medications or substances that affect glucose metabolism. It is important to inform healthcare providers about all current medications to ensure safe and effective use.